Compound 17 - Compound Search

US20250197382, Compound 17 PubChem CID 177373017

O=C(Nc1cc2c(c(N3CCC(F)(F)CC3)c1)OCC2)c1ccc(S(=O)(=O)NCCO)cc1N1CCC2(CC1)CC2

1,9,12,15,18,21-hexaoxodocosahydro-1H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosin-17 CAS 148031-34-9 PubChem CID 177678985

CC(=O)O.NC(=O)[C@@H]1CSSCCC(=O)N[C@@H](CCCCN=C(N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N2CCCC2C(=O)N1

US20250230129, Compound 17 PubChem CID 177692261

CNC(=O)NC1CCN(C(=O)[C@@H](CCCCN)CC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)N(CCN)Cc2ccccc2)CC1

Salicylic Acid; 2-Hydroxybenzoic Acid; Lamivudine Imp. C (EP); Sulfasalazine Imp. H (EP); Carbasalate Calcium Imp. C (EP); Mesalazine Imp. H (EP); Acetylsalicylic Acid Imp. C (EP); Hydroxyethyl Salicylate Imp. A (EP); Lamivudine related; Salicylic acid CCI14008X; Acetylsalicylic Acid Impurity C; Carbasalate Calcium Impurity C; Hydroxyethyl Salicylate Impurity A; Lamivudine Impurity C; Mesalazine Impurity H; Sulfasalazine Impurity H; Carbasalate Impurity C CAS 69-72-7 PubChem CID 338

O=C(O)c1ccccc1O

Estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, compd. with piperazine (1:1); Estrone, hydrogen sulfate, compd. with piperazine (1:1) (8CI); Piperazine, compd. with 3-(sulfooxy)estra-1,3,5(10)-trien-17-one (1:1) (9CI); Piperazine, compd. with estrone hydrogen sulfate (1:1) (8CI); 3-Sulfatoxyestra-1,3,5(10)-trien-17-one piperazine salt; Estrone sulfate piperazine salt; Estropipate; Harmogen; Ogen; Piperazine estrone sulfate; Sulestrex; Sulestrex piperazine CAS 7280-37-7 PubChem CID 5284555

C1CNCCN1.C[C@]12CC[C@@H]3c4ccc(OS(=O)(=O)O)cc4CC[C@H]3[C@@H]1CCC2=O

(11beta,16beta)-9-Fluoro-11,17-dihydroxy-16-methyl-21-[(1-oxopentyl)oxy]-pregna-1,4-diene-3,20-dione; Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,17,21-trihydroxy-16beta-methyl-, 21-valerate (7CI,8CI); Betamethasone 21-valerate; Betamethasone Valerate Imp. E (EP); Betamethasone Valerate USP Related Compound A; Betamethasone Valerate USP RC A; USP Betamethasone Valerate Related Compound A; CCI 1617; Ph Eur Betamethasone Valerate Impurity E; CS valerate; Betamethasone-21-valerate; Betamethasone Valerate Related Compound A; Betamethasone Valerate Impurity E CAS 2240-28-0 PubChem CID 92922

CCCCC(=O)OCC(=O)[C@@]1(O)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C

(5a)-17-(3-Buten-1-yl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one Hydrochloride; 17-(3-Butenyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one Hydrochloride; 17-But-3-enyl-4,5a-epoxy-3,14-dihydroxymorphinan-6-one Hydrochloride CAS 131670-05-8 PubChem CID 71314313

C=CCCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5.Cl

(1R,3aS,3bS,5aS,9aS,9bR,11aS)-11a-Ethyl-1-ethynyl-10-methylidene-2,3,3a,3b,4,5,5a,8,9,9a,9b,10,11,11a-tetradecahydro-1H-cyclopenta[a]phenanthren-1-ol CAS 201360-82-9 PubChem CID 71587628

C#C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4C=CCC[C@@H]4[C@H]3C(=C)C[C@@]21CC

(aS,5a,7a)-17-(3-Buten-1-yl)-a-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-a-methyl-6,14-ethenomorphinan-7-methanol; 6,14-Ethenomorphinan-7-methanol, 17-(3-butenyl)-a-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-a-methyl-, (aS,5a,7a)- (9CI); N-(3-Butenyl)norbuprenorphine; (2S)-2-[17-(But-3-enyl)-4,5a-epoxy-3-hydroxy-6-methoxy-6a,14-ethano-14a-morphinan-7a-yl]-3,3-dimethylbutan-2-ol; N-But-3-enylnorbuprenorphine; Buprenorphine Imp. A (EP) CAS 457071-73-7 PubChem CID 56843102

C=CCCN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@]2(OC)CC[C@@]3(C[C@@H]2[C@](C)(O)C(C)(C)C)[C@H]1C5

Androsta-1,4-diene-17-carbothioic acid, 17-(acetyloxy)-6,9-difluoro-11-hydroxy-16-methyl-3-oxo-, S-(fluoromethyl) ester, (6alpha,11beta,16alpha,17alpha)-; 6alpha,9-difluoro-17-[[(fluoromethyl)sulfanyl]carbonyl]-11beta-hydroxy-16alpha-methyl-3-oxoandrosta-1,4-dien-17alpha-yl acetate; Fluticasone acetate; Fluticasone Propionate Imp. C (EP); CAF (GW694301X); GW 872664X; TAF (GW675713X); 6-des-fluoro 698 (GW836850X); GSK465433A and GSK1322631A; 5-chloro-furoyl 698 (GSK180878A); TA-TAF dimer (GW871519X); unidentified impurity with RRT 1.23; disulphide dipropionate dithioketone (GR 247095X); fluticasone acetate (CCI 22341); dithio (GR 269949X) CAS 80474-24-4 PubChem CID 10005640

CC(=O)O[C@]1(C(=O)SCF)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C

Fluticasone Propionate Imp. B (EP); 6alpha,9-Difluoro-11beta-hydroxy-16alpha-methyl-3-oxo-17-(propanoyloxy)androsta-1,4-dien-17beta-carbo(thioperoxoic) SO-Acid; [[6alpha,9-Difluoro-11beta-hydroxy-16alpha-methyl-3-oxo-17-(propanoyloxy)androsta-1,4-dien-17beta-yl]carbonyl]sulphenic Acid CAS 948566-12-9 PubChem CID 71587891

CCC(=O)O[C@]1(C(=O)SO)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C

(1S,3aS,3bR,5aR,9aR,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydroindeno[5,4-f]chromen-7-one CAS 4424-45-7 PubChem CID 247853

C[C@]12CCC(=O)O[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O

2-hydroxy-1-[(3R,5S,8S,9S,10S,11S,13S,14S,17R)-3,11,17-trihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone CAS 302-91-0 PubChem CID 92748

C[C@]12CC[C@@H](O)C[C@@H]1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO

3,17-Dihydroxy-19-nor-17alpha-pregna-1,3,5(10)-trien-20-yn-6-one; Ethinylestradiol Imp. G (EP); 6-Oxoethinylestradiol; 6-Ketoethinylestradiol; Ethinyl Estradiol Related Compound A; Ethinylestradiol Impurity G CAS 38002-18-5 PubChem CID 11209099

C#C[C@]1(O)CC[C@H]2[C@@H]3CC(=O)c4cc(O)ccc4[C@H]3CC[C@@]21C

2-((8S,9S,10R,11S,13S,14S,17R)-17-((ethoxycarbonyl)oxy)-11-hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl propionate CAS 671225-26-6 PubChem CID 124637835

CCOC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C

CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC

Morphinan-6-one, 7,8-didehydro-4,5-epoxy-3-hydroxy-17-methyl-, (5a)-; Morphinan-6-one, 7,8-didehydro-4,5a-epoxy-3-hydroxy-17-methyl- (8CI); Morphinone (6CI); Hydromorphone RC A CII (USP); Morphinone CAS 467-02-7 PubChem CID 5459823

CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)C=C[C@H]3[C@H]1C5

13-Ethyl-11-methylidene-18,19-dinor-17a-pregn-4-en-20-yne-3ss,17-diol; 3ss-Hydroxydesogestrel; (3ss,17a)-13-Ethyl-11-methylene-18,19-dinorpregn-4-en-20-yne-3,17-diol; Desogestrel Imp. E (EP) CAS 70805-85-5 PubChem CID 9858547

C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C[C@@H](O)CC[C@@H]4[C@H]3C(=C)C[C@@]21CC

(8R,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one 11 Deoxycortisol 11 Desoxycortisol 11 Desoxycortisone 11-Deoxycortisol 11-Desoxycortisol 11-Desoxycortisone Cortexo CAS 152-58-9 PubChem CID 440707

C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO

Spiro[androsta-1,4-diene-17,5'-[1,3]oxathiolane]-2',3,4'-trione, 6,9-difluoro-11-hydroxy-16-methyl-, (6a,11ss,16a,17a)- ; 6a,9a-Difluoro-11ss-hydroxy-16a-methyl-2',3,4'-trioxo-17a-spiro(androsta-1,4-diene-17,5'-(1,3)oxathiolane); GR 80723X; unidentified impurity with RRT 1.23; disulphide dipropionate dithioketone (GR 247095X); dithio (GR 269949X); Fluticasone Propionate Related Compound B CAS 219719-95-6 PubChem CID 71587644

C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@]12OC(=O)SC2=O

Compound Database